(2026) -
Chronological (1664 items)
(All links open in new tab)
| Oct 9, 2026 |
Federal marijuana rescheduling means institutional capital is coming to cannabis investing
The U.S. cannabis industry has spent years waiting for a single catalyst from the federal government to change its trajectory. Investors have watched for banking reform, rescheduling, federal legalization and tax relief as though one event might suddenly erase the barriers that have kept traditional capital on the sidelines. After more than three decades in capital markets, I do not think industries mature that way. Capital tends to move when a series of risks become measurable, familiar and ultimately manageable. |
|---|---|
| Oct 9, 2026 |
The Marijuana Legalization Paradox: More Legal Cannabis, Fewer Teen Users
Most Americans now live in a jurisdiction where cannabis is legal — and use by teens has never been lower. Yes, you read that right. According to the latest findings from the U.S. Centers for Disease Control and Prevention, fewer young people nationwide are using marijuana today than at any time in the last 30 years. |
| Oct 9, 2026 |
NL’s only legal medicinal cannabis grower goes bust
Patients who use medicinal cannabis face having to switch to imported products after the only licensed grower in the Netherlands was declared bankrupt on Thursday. A court in Groningen declared Veendam-based Bedrocan bankrupt two weeks after the company had applied for protection from its creditors. The firm, whose main growing site is in Emmeloord, employs around 70 people. Bedrocan ran into trouble after the health ministry ended its contract at the start of this year. All medicinal cannabis sold in Dutch pharmacies is bought and distributed by the state-run Bureau for Medicinal Cannabis (BMC). |
| Oct 9, 2026 |
More Than A Third Of Hikers Use Marijuana To Enhance Their Experience On The Trail, Poll Shows
A significant number of people who hike enhance their experience on the trail with marijuana, according to a new poll. The expedition company Climbing Kilimanjaro surveyed 1,008 U.S. adult hikers, finding that more than a third (35 percent) have hiked while under the influence of cannabis—the most popularly used substance in the poll. |
| Oct 8, 2026 |
Europe Now a Growth Priority for North American Cannabis Capital
North American institutional cannabis investors now see the European medical market as a crucial driver of growth, a new survey suggests. ATB Cormark Capital Markets’ latest ‘Capital Markets Cannabis Investor Sentiment Survey’ found that nearly half (47.1%) of US-focused respondents believe multi-state operators (MSOs) should participate in international medical cannabis markets, up from 37.5% in Spring 2026, with the share saying MSOs should not participate collapsing from 37.5% to 11.8%. |
| Oct 8, 2026 |
Shen says he does not support legalizing cannabis in Taiwan
TAIPEI (Taiwan News) — Puma Shen (???), the DPP’s mayoral candidate in Taipei, said in a televised interview Wednesday that he would not push for drug decriminalization and does not support legalizing cannabis in Taiwan. Shen was responding to questions from media personality and politician Jaw Shao-kang (???) about his stance on drug policy, per CNA. Jaw served one term as a Taipei city councilor before being elected to the Legislative Yuan in the 1990s and was the KMT’s vice-presidential nominee in the 2024 election. |
| Oct 8, 2026 |
Tilray posts record revenue but cannabis sales drop, shares fall 4% amid profit pressure
Tilray Brands reported a first-quarter revenue record, rising 23% year-over-year, driven by gains in its beer and distribution segments following the BrewDog acquisition. However, its core cannabis sales declined, falling to $56.1 million, causing investor concern and a 4% drop in its stock price. Despite higher revenue and gross profit, adjusted earnings before interest, taxes, depreciation, and amortization decreased due to factors like global fuel surcharges. The company remains optimistic with a net cash position and reduced debt, but the market will watch closely to see if cannabis sales stabilize and profitability improves in coming quarters. Canopy Growth and Aurora Cannabis, more focused on cannabis, showed smaller stock declines, indicating Tilray's mixed results are company-specific rather than sector-wide. |
| Oct 7, 2026 |
Cannabis Becomes Canada’s Fifth-Most Important Cash Crop
Cannabis has become one of Canada’s most important cash crops since it was first made legal for adult use in 2018. Cannabis legalization transformed the sector from less than 1% of total farm receipts in 2016 to a competitor with crops like soybeans and corn, outpacing durum wheat, barley, lentils, and tobacco. According to Statistics Canada’s annual farm cash receipts data, cannabis farm receipts (Cannabis seeds, vegetative plants, and flowering tops, including leaves) in Canada have grown from $94.8 million in 2016 to more than $3 billion in 2025. |
| Oct 7, 2026 |
Albania Adopts Cannabis Industry Tracking Rules
Albania’s government has adopted new rules for tracking and tracing the cannabis industry. Such rules are commonly referred to as ‘seed-to-sale’ tracking in many legal markets and are standard for emerging cannabis industries around the globe. “The new framework establishes an oversight system covering the entire chain of activity from the import of seeds, seedlings and clones to cultivation, harvesting, drying, processing, storage, transportation and export. It also sets out procedures for the seizure, confiscation and destruction of cannabis-related materials.” reported Albanian Daily News in its local coverage. |
| Oct 7, 2026 |
New Adult-Use Cannabis Retail Restrictions Take Effect In Ohio
New restrictions on the size and potency of adult-use cannabis products took effect this week in Ohio, WCMH reports. The changes could force some businesses to remove products from their shelves. Under the rules enacted by the Division of Cannabis Control (DCC), cannabis flower is now limited to one ounce per package and vape cartridges are limited to three devices per package. Cartridges also now have a THC cap of 90% and cannot exceed two grams. Regulators have also determined that a single serving from a vape product is a two-second inhalation. |
| Oct 7, 2026 |
Dutch Cannabis Patients Facing 10-Month Supply Gap, Many With ‘No Therapeutic Alternative’
Thousands of Dutch patients are facing a 10-month supply gap for medically essential Bedrocan products, including varieties clinicians consider irreplaceable for children with treatment-resistant epilepsy. Last week, Bedrocan announced that its key Dutch entities had taken emergency financial measures to avoid bankruptcy. The crisis arrives as roughly three-quarters of Bedrocan’s European production capacity falls out of the Dutch patient-supply chain, with no import authorisation granted for Danish-produced material to replace it in the interim. |
| Oct 7, 2026 |
PM says no to cannabis cultivation in Cambodia
Prime Minister Hun Manet has restated his firm opposition to cannabis cultivation in Cambodia, saying the government would not be able to effectively control its production and domestic use. The premier made his remarks today, while presiding over the University of Health Sciences’ the 80th anniversary celebrations in Phnom Penh. “My position, even before I became prime minister, was to oppose the cultivation of cannabis in Cambodia,” he said. |
| Oct 7, 2026 |
Experts issue medical cannabis warning to millions of Britons
Nearly two million unlicensed cannabis items were prescribed privately in England over the past 12 months according to new figures, prompting a warning over potential risks to patients. England’s patient safety commissioner Professor Henrietta Hughes said that immediate measures are required to safeguard people purchasing medical cannabis on online platforms. |
| Oct 7, 2026 |
How Nextleaf Solutions Ltd. (CN: OILS) Is Balancing Brand Growth Against Margin Pressure in Canadian Cannabis
Nextleaf Solutions Ltd. (CN:OILS) is trying to grow a portfolio of consumer cannabis brands and an export Business while absorbing the pricing compression that continues to weigh on Canada's legal market. Its fiscal 2026 results so far show the tension clearly: a profitable first quarter was followed by two loss-making quarters, as gross Margin narrowed and the company spent on sales infrastructure, a second processing site and export capability. |
| Oct 6, 2026 |
Do government-run cannabis retail sales work?
Key points in this article: Minnesota is one of at least two adult-use cannabis states that allow local governments to operate cannabis retail. Anoka Cannabis Co., Minnesota’s first city-run cannabis retail store, opened Feb. 5. The store pays no federal taxes, sidestepping Internal Revenue Code Section 280E. Other Minnesota cities are seeking retail cannabis licenses. When Minnesota legalized adult-use cannabis, cities saw an opportunity in the state’s unique law to create a new revenue stream: a marijuana business that could be run much like the municipal liquor stores that have been in business since 1937. In Anoka, a Twin Cities suburb, the result is Anoka Cannabis Co., a city-owned cannabis store that opened Feb. 5 adjacent to the liquor store the city has owned and operated for 33 years. |
| Oct 6, 2026 |
Aurora Cannabis Inc. (TSX:ACB) Rallies 14.16% as Upside Momentum Strengthens
Aurora Cannabis Inc. gained 14.16% on 5 October 2026 and finished the session in positive territory. The move points to stronger marginal Demand for the shares and a shift toward a more constructive short-term setup. The immediate backdrop is not explained by price action alone. Recent company updates highlighted continued international expansion, including European market progress and acquisition-led additions to the medical platform. Investor attention is also elevated by an unsolicited takeover process, with the company continuing to advise shareholders while reviewing developments through its special committee. That combination can encourage investors to re-evaluate the balance between company-specific optionality and execution risk. |
| Oct 6, 2026 |
Medical cannabis has been legalised in the UK. So why is it still a surprise?
Mention to anyone in a pub that cannabis might soon be legally prescribed in Britain and you’re sure to get the side-eye. It’s been legal since 2018, but the language we use about cannabis in the UK doesn’t reflect that. The trouble is that it’s easy to confuse two whole different things. Recreational marijuana is still not legal. You can get a prescription for medical cannabis. Separating the two makes it a whole lot less complicated. |
| Oct 6, 2026 |
Uganda Minister To Lead Cannabis Industry Organization
The Uganda Medical Cannabis and Industrial Hemp Cooperative Society (UMCHICS) was launched to help organize and promote Uganda’s emerging legal medical cannabis and hemp industry. The nation’s Minister for Information, Communications Technology and National Guidance, Justine Kasule Lumumba, will serve as the newly formed organization’s acting chairperson. “We want our members to be judged not simply by what they grow, but by how responsibly they operate,” Minister Lumumba said, according to Nile Post. |
| Oct 6, 2026 |
Florida could get another shot at legalizing weed
Pro-cannabis advocates in the Sunshine State are once again trying to legalize adult use. Two separate measures were recently submitted to the state in hopes of getting on the ballot in 2028. The first initiative would legalize the possession and consumption of cannabis for adults 21 and over. The measure would limit possession to two ounces of marijuana, including no more than five grams of concentrates. |
| Oct 6, 2026 |
No Progress After 2 Years of South African Cannabis Act
South Africa is often described as one of the African countries that decriminalised cannabis, but that description becomes less straightforward the closer one looks at what followed the Constitutional Court’s 2018 judgment. In Minister of Justice v Prince, the Court held that criminalising an adult’s private use or possession of cannabis for personal consumption, and private cultivation for that purpose, was an unjustifiable infringement of a person’s constitutional right to privacy. Crucially, the Court did not legalise commercial dealing and did not create an unrestricted right to possess any quantity, but it drew an important line between private and commercialised conduct. Eight years later, South Africa is still trying to decide exactly where that line should be drawn. |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84